Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China's Medtech Regulatory Reforms Yet To Enter Steady Path

Executive Summary

Medical device companies operating in China are still looking for clearer guidance that will help them make the most of the wide-ranging regulatory reforms introduced in the country since 2014.


Related Content

China Shows More Of An Open Door To Overseas Medtech Industry
Unlocking Legalities: Antitrust Risk Rises In China
China’s Fast-Track Innovative Device Pathway Delivers For Few
China's Plan to Exempt More Devices From Trials Will Save Companies Effort And Cost
China's Fast Track Process For Medical Devices Growing With 46 Products Admitted So Far
China Nod At Regulatory Improvements Will Widen Doors For US Medtech
China FDA issues 'user-friendly' guidance on medical device registration studies; waivers may prove a challenge





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts